A Study to Investigate the Effect of Itraconazole on the Way the Body Absorbs, Distributes, and Gets Rid of ACT-1004-1239 Given as a Single Dose of 10 mg to Healthy Male Subjects

NCT05549531 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ACT-1004-1239 (10 mg)
DRUG: Itraconazole (200 mg, o.d.)

Sponsor

Idorsia Pharmaceuticals Ltd.